Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-L-iduronidase

Clin Chim Acta. 2001 Oct;312(1-2):81-6. doi: 10.1016/s0009-8981(01)00593-9.

Abstract

Background: Mucopolysaccharidosis type I (MPS I) is a disease caused by deficiency of the enzyme alpha-L-iduronidase (IDUA). Since no treatment is currently available for this disorder, the detection of heterozygotes is very important for genetic counseling and prenatal diagnosis. The objective of the present study was to characterize plasma IDUA from MPS I heterozygotes in an attempt to distinguish it from that of normal individuals.

Methods: We determined the optimum pH, Km, Vmax and Calpha (Vmax/Km) of the reaction and the thermal stability of IDUA at 50 degrees C.

Results: MPS I heterozygotes can be separated from normal individuals on the basis of Km, Calpha and thermal stability of the enzyme.

Conclusions: Taking into consideration the clinical status of the homozygous offspring, we were able to subdivide the MPS I heterozygotes into various subgroups (Hurler, Scheie or Hurler/Scheie compound), and verified that the Hurler subgroup had a lower optimum pH for IDUA activity than controls and other MPS I subgroups, and that all MPS I subgroups had higher Km and lower Calpha when compared to controls.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Enzyme Stability
  • Heterozygote
  • Humans
  • Hydrogen-Ion Concentration
  • Iduronidase / blood*
  • Iduronidase / chemistry
  • Iduronidase / metabolism
  • Mucopolysaccharidosis I / blood*
  • Mucopolysaccharidosis I / genetics*
  • Pedigree
  • Reference Values

Substances

  • Iduronidase